BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 27873306)

  • 1. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
    Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
    J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated leukocyte cell adhesion molecule expression is up-regulated in the development of endometrioid carcinoma.
    Liang S; Huang C; Jia S; Wang B
    Int J Gynecol Cancer; 2011 Apr; 21(3):523-8. PubMed ID: 21430457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone.
    Hansen AG; Arnold SA; Jiang M; Palmer TD; Ketova T; Merkel A; Pickup M; Samaras S; Shyr Y; Moses HL; Hayward SW; Sterling JA; Zijlstra A
    Cancer Res; 2014 Mar; 74(5):1404-15. PubMed ID: 24385212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sonic Hedgehog Signalling Activation Contributes to ALCAM Over-Expression and Poor Clinical Outcome in Patients with Oral Squamous Cell Carcinoma.
    Chen G; Yan M; Li RR; Chen WT
    Chin J Dent Res; 2018; 21(1):31-40. PubMed ID: 29507910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of Activated Leucocyte Cell Adhesion Molecule (ALCAM/CD166) in Infantile Neuroblastoma.
    Wachowiak R; Mayer S; Kaifi J; Gebauer F; Izbicki JR; Lacher M; Bockhorn M; Tachezy M
    Anticancer Res; 2016 Aug; 36(8):3991-5. PubMed ID: 27466504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-148b suppressed non-small cell lung cancer progression via inhibiting ALCAM through the NF-κB signaling pathway.
    Jiang Z; Zhang J; Chen F; Sun Y
    Thorac Cancer; 2020 Feb; 11(2):415-425. PubMed ID: 31883226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer.
    Jeong YJ; Oh HK; Park SH; Bong JG
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29315254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation.
    Penna E; Orso F; Cimino D; Vercellino I; Grassi E; Quaglino E; Turco E; Taverna D
    Cancer Res; 2013 Jul; 73(13):4098-111. PubMed ID: 23667173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion.
    Achiha T; Kijima N; Kodama Y; Kagawa N; Kinoshita M; Fujimoto Y; Nonaka M; Fukai J; Inoue A; Nishida N; Yamanaka T; Harada A; Mori K; Tsuyuguchi N; Uda T; Ishibashi K; Tomogane Y; Sakamoto D; Shofuda T; Yoshioka E; Kanematsu D; Mano M; Luu B; Taylor MD; Kanemura Y; Kishima H
    PLoS One; 2020; 15(12):e0243272. PubMed ID: 33270750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
    Tachezy M; Zander H; Gebauer F; Marx A; Kaifi JT; Izbicki JR; Bockhorn M
    J Surg Res; 2012 Sep; 177(1):e15-20. PubMed ID: 22482754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth.
    Ferragut F; Cagnoni AJ; Colombo LL; Sánchez Terrero C; Wolfenstein-Todel C; Troncoso MF; Vanzulli SI; Rabinovich GA; Mariño KV; Elola MT
    Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1338-1352. PubMed ID: 30905597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells.
    Fernández MM; Ferragut F; Cárdenas Delgado VM; Bracalente C; Bravo AI; Cagnoni AJ; Nuñez M; Morosi LG; Quinta HR; Espelt MV; Troncoso MF; Wolfenstein-Todel C; Mariño KV; Malchiodi EL; Rabinovich GA; Elola MT
    Biochim Biophys Acta; 2016 Oct; 1860(10):2255-68. PubMed ID: 27130882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.
    Van Gool IC; Stelloo E; Nout RA; Nijman HW; Edmondson RJ; Church DN; MacKay HJ; Leary A; Powell ME; Mileshkin L; Creutzberg CL; Smit VT; Bosse T
    Mod Pathol; 2016 Feb; 29(2):174-81. PubMed ID: 26743472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
    Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
    Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients.
    Sawhney M; Matta A; Macha MA; Kaur J; DattaGupta S; Shukla NK; Ralhan R
    Int J Cancer; 2009 May; 124(9):2098-105. PubMed ID: 19142865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.
    Davies S; Jiang WG
    Anticancer Res; 2010 Apr; 30(4):1163-8. PubMed ID: 20530423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression profiling and the role of ALCAM modulating tumor growth and metastasis in benzo[a]pyrene-transformed 16HBE cells.
    Li L; Chen J; Wang Y; Zhou C; Ma X; Fu J; Yao B; Zhao P
    Toxicology; 2020 Sep; 442():152539. PubMed ID: 32681969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.
    Carbotti G; Orengo AM; Mezzanzanica D; Bagnoli M; Brizzolara A; Emionite L; Puppo A; Centurioni MG; Bruzzone M; Marroni P; Rossello A; Canevari S; Ferrini S; Fabbi M
    Int J Cancer; 2013 Jun; 132(11):2597-605. PubMed ID: 23169448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM.
    Song Q; Xu Y; Yang C; Chen Z; Jia C; Chen J; Zhang Y; Lai P; Fan X; Zhou X; Lin J; Li M; Ma W; Luo S; Bai X
    Cancer Res; 2014 Jun; 74(11):3031-42. PubMed ID: 24710410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.